Heerlen, NL, 31 Mar 2016 18:00 CEST
Royal DSM, the global science-based company active in health, nutrition and materials, announces that all members of its Executive Committee purchase ordinary shares in Royal DSM, expressing their confidence in the growth prospects of the company.
All eight members of the DSM Executive Committee have decided to purchase ordinary shares in Royal DSM, partly by own investments and partly by converting a part of their Short Term Incentive cash into shares. The total amount is approximately 35,000 shares, representing circa €200,000 cash per individual. Details of the transactions are provided in the notification to the Autoriteit Financiële Markten (AFM), according to the applicable regulations.
In addition, the members of the Executive Committee who had options that expire in March 2016, exercised these vested stock incentives which were granted in 2008.